Advertisement
ANGO vs BLFS
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANGO is a Buy and BLFS is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ANGO’s FA Score shows that 0 FA rating(s) are green whileBLFS’s FA Score has 1 green FA rating(s).
- ANGO’s FA Score: 0 green, 5 red.
- BLFS’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ANGO’s TA Score shows that 5 TA indicator(s) are bullish while BLFS’s TA Score has 4 bullish TA indicator(s).
- ANGO’s TA Score: 5 bullish, 5 bearish.
- BLFS’s TA Score: 4 bullish, 4 bearish.
Price Growth
ANGO (@Pharmaceuticals: Other) experienced а -0.84% price change this week, while BLFS (@Pharmaceuticals: Other) price change was -3.40% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.13%. For the same industry, the average monthly price growth was -3.06%, and the average quarterly price growth was +8.48%.
Reported Earning Dates
ANGO is expected to report earnings on Oct 02, 2025.
BLFS is expected to report earnings on Nov 06, 2025.
Industries' Descriptions
@Pharmaceuticals: Other (-1.13% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
| ANGO | BLFS | ANGO / BLFS | |
| Capitalization | 439M | 1.18B | 37% |
| EBITDA | 1.74M | 17.4M | 10% |
| Gain YTD | 16.594 | -4.854 | -342% |
| P/E Ratio | N/A | N/A | - |
| Revenue | 292M | 93.5M | 312% |
| Total Cash | 55.9M | 81.8M | 68% |
| Total Debt | 5M | 23.8M | 21% |
ANGO | BLFS | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 78 | 65 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 68 Overvalued | 99 Overvalued | |
PROFIT vs RISK RATING 1..100 | 94 | 93 | |
SMR RATING 1..100 | 95 | 92 | |
PRICE GROWTH RATING 1..100 | 45 | 58 | |
P/E GROWTH RATING 1..100 | 51 | 13 | |
SEASONALITY SCORE 1..100 | n/a | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ANGO's Valuation (68) in the Medical Specialties industry is in the same range as BLFS (99). This means that ANGO’s stock grew similarly to BLFS’s over the last 12 months.
BLFS's Profit vs Risk Rating (93) in the Medical Specialties industry is in the same range as ANGO (94). This means that BLFS’s stock grew similarly to ANGO’s over the last 12 months.
BLFS's SMR Rating (92) in the Medical Specialties industry is in the same range as ANGO (95). This means that BLFS’s stock grew similarly to ANGO’s over the last 12 months.
ANGO's Price Growth Rating (45) in the Medical Specialties industry is in the same range as BLFS (58). This means that ANGO’s stock grew similarly to BLFS’s over the last 12 months.
BLFS's P/E Growth Rating (13) in the Medical Specialties industry is somewhat better than the same rating for ANGO (51). This means that BLFS’s stock grew somewhat faster than ANGO’s over the last 12 months.
| ANGO | BLFS | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 79% | 3 days ago 90% |
| Stochastic ODDS (%) | 3 days ago 78% | 3 days ago 81% |
| Momentum ODDS (%) | 3 days ago 74% | 3 days ago 87% |
| MACD ODDS (%) | 3 days ago 73% | 3 days ago 88% |
| TrendWeek ODDS (%) | 3 days ago 74% | 3 days ago 85% |
| TrendMonth ODDS (%) | 3 days ago 73% | 3 days ago 86% |
| Advances ODDS (%) | 11 days ago 76% | 3 days ago 77% |
| Declines ODDS (%) | 4 days ago 73% | 5 days ago 85% |
| BollingerBands ODDS (%) | 5 days ago 70% | 3 days ago 84% |
| Aroon ODDS (%) | 3 days ago 68% | 3 days ago 81% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| BBGSX | 17.31 | 0.16 | +0.93% |
| Bridge Builder Small/Mid Cap Growth | |||
| PRVRX | 13.56 | 0.11 | +0.82% |
| PGIM Quant Solutions Large-Cap Val R | |||
| BISLX | 11.73 | 0.09 | +0.77% |
| Brown Advisory Sustainable Intl Ldrs Inv | |||
| DGLAX | 21.03 | 0.11 | +0.53% |
| BNY Mellon Global Stock - A | |||
| OILGX | 27.64 | 0.10 | +0.36% |
| Optimum Large Cap Growth Instl | |||
ANGO and
Correlation & Price change
A.I.dvisor indicates that over the last year, ANGO has been loosely correlated with MXCT. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if ANGO jumps, then MXCT could also see price increases.
| Ticker / NAME | Correlation To ANGO | 1D Price Change % | ||
|---|---|---|---|---|
| ANGO | 100% | +0.85% | ||
| MXCT - ANGO | 36% Loosely correlated | N/A | ||
| BLFS - ANGO | 34% Loosely correlated | +2.15% | ||
| RGEN - ANGO | 32% Poorly correlated | +3.23% | ||
| FLGT - ANGO | 32% Poorly correlated | +2.54% | ||
| ABT - ANGO | 32% Poorly correlated | +0.18% | ||
More | ||||
BLFS and
Correlation & Price change
A.I.dvisor indicates that over the last year, BLFS has been loosely correlated with RGEN. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if BLFS jumps, then RGEN could also see price increases.
| Ticker / NAME | Correlation To BLFS | 1D Price Change % | ||
|---|---|---|---|---|
| BLFS | 100% | +2.15% | ||
| RGEN - BLFS | 59% Loosely correlated | +3.23% | ||
| A - BLFS | 51% Loosely correlated | +1.23% | ||
| RVTY - BLFS | 50% Loosely correlated | +1.23% | ||
| TWST - BLFS | 49% Loosely correlated | +0.60% | ||
| AZTA - BLFS | 49% Loosely correlated | -0.66% | ||
More | ||||